Archive - April 2021
Pfizer acquires Amplyx Pharmaceuticals, including new potential class of therapeutics
GSK’s revenue drops by 18% in Q1 as performance pressures mount
First UK-based clinical trial focused viral vector manufacturer announces launch
Triple combo cystic fibrosis therapy Kaftrio scores EU label expansion
UK-based CRO Charnwood Molecular reveals plans for ‘significant’ expansion in 2021
Daiichi Sankyo’s cholesterol-lowering drugs recommended for NHS use
Novartis announces delay in UK cholesterol drug study
Lilly cuts 2021 guidance to reflect ‘lower expected revenue’ from COVID-19 antibody sales